NCT00136513View on ClinicalTrials.gov

SB-743921 In Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2004

Conditions
Solid Tumor Cancer
Interventions
DRUG

SB-743921

Trial Locations (2)

15232

GSK Investigational Site, Pittsburgh

53792

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY